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A SUMO-targeted ubiquitin ligase is involved in 
the degradation of the nuclear pool of the SUMO 
E3 ligase Siz1
Jason W. Westerbeck*,†, Nagesh Pasupala*, Mark Guillotte, Eva Szymanski, Brooke C. Matson, 
Cecilia Esteban, and Oliver Kerscher
Biology Department, The College of William & Mary, Williamsburg, VA 23187 
ABSTRACT The Slx5/Slx8 heterodimer constitutes a SUMO-targeted ubiquitin ligase (STUbL) 
with an important role in SUMO-targeted degradation and SUMO-dependent signaling. This 
STUbL relies on SUMO-interacting motifs in Slx5 to aid in substrate targeting and carboxy-
terminal RING domains in both Slx5 and Slx8 for substrate ubiquitylation. In budding yeast 
cells, Slx5 resides in the nucleus, forms distinct foci, and can associate with double-stranded 
DNA breaks. However, it remains unclear how STUbLs interact with other proteins and their 
substrates. To examine the targeting and functions of the Slx5/Slx8 STUbL, we constructed 
and analyzed truncations of the Slx5 protein. Our structure–function analysis reveals a do-
main of Slx5 involved in nuclear localization and in the interaction with Slx5, SUMO, Slx8, and 
a novel interactor, the SUMO E3 ligase Siz1. We further analyzed the functional interaction of 
Slx5 and Siz1 in vitro and in vivo. We found that a recombinant Siz1 fragment is an in vitro 
ubiquitylation target of the Slx5/Slx8 STUbL. Furthermore, slx5∆ cells accumulate phospho-
rylated and sumoylated adducts of Siz1 in vivo. Specifically, we show that Siz1 can be ubiqui-
tylated in vivo and is degraded in an Slx5-dependent manner when its nuclear egress is pre-
vented in mitosis. In conclusion, our data provide a first look into the STUbL-mediated 
regulation of a SUMO E3 ligase.
INTRODUCTION
Eukaryotic cells use the addition and removal of posttranslational 
modifiers (PTMs) to control the cell division cycle. Ubiquitin and 
SUMO are two small proteinaceous PTMs that modulate protein 
fate and function. Ubiquitin is best known for its role in the targeted 
degradation of important cell-cycle regulators, but it also holds 
many nonproteolytic functions (reviewed by Ulrich and Walden, 
2010; Okita and Nakayama, 2012; Yao and Ndoja, 2012). In contrast, 
SUMO modification does not necessarily lead to degradation of the 
proteins to which it is attached. Instead, sumoylation modulates the 
localization, interaction, and activity of target proteins, including 
those involved in efficient cell cycle progression, DNA replication 
and repair, transcriptional regulation, and the formation of nuclear 
bodies, to name just a few (Wang and Dasso, 2009).
All eukaryotic cells carry several copies of the gene encoding 
ubiquitin, a conserved 76–amino acid protein. Ubiquitin shares only 
limited sequence identity with other ubiquitin-like proteins (Ubls)—
for example, SUMO (18%)—but the overall “ubiquitin fold” is struc-
turally conserved. Mammalian cells encode three different SUMO 
isoforms—SUMO1, 2, and 3—whereas budding yeast cells express 
only one—Smt3—hereafter referred to as yeast SUMO. After trans-
lation, both ubiquitin and SUMO precursors are made conjugation 
competent by processing through ubiquitin- and SUMO-specific 
proteases, respectively. This processing exposes a carboxy-terminal 
diglycine motif that is subsequently linked to a lysine side chain of a 
target protein. The ATP-dependent process of substrate selection 
and linkage is mechanistically conserved between Ubls. Generally, 
ubiquitylation and sumoylation of proteins depend on the stepwise 
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transcriptional regulators Mot1 and Matalpha2 (in vivo), the homolo-
gous recombination protein Rad52 (in vitro), and sumoylated Nfi1/
Siz2 (in vitro; Zhang et al., 2006; Nagai et al., 2008; Cook et al., 
2009; Wang and Prelich, 2009; Xie et al., 2010; Garza and Pillus, 
2013). In contrast, Ris1 has been proposed to target cytosolic pro-
teins, including sumoylated Pac1, a microtubule-associated protein 
(Alonso et al., 2012). Rad18, a SIM-containing ubiquitin ligase that is 
stimulated by sumoylation of its substrate, the sliding clamp protein 
PCNA, is likely the newest member of a growing family of STUbLs 
(Parker and Ulrich, 2012). Apart from specific protein substrates, 
among the most important targets of STUbLs may be SUMO chains. 
This is illustrated by the observation that STUbL mutants accumulate 
high–molecular weight SUMO chains (Uzunova et al., 2007; Xie 
et al., 2007). However, our mechanistic understanding of SUMO 
chains is limited, and whether these polymers are beneficial or det-
rimental to cellular processes may depend on several factors, in-
cluding growth conditions and genetic background (Uzunova et al., 
2007; Mullen et al., 2011; Tan et al., 2013). In general, there is also 
clear evidence that the accumulation of SUMO conjugates in SUMO 
protease mutants is linked to vegetative growth, cell cycle progres-
sion, and other defects (Li and Hochstrasser, 1999, 2000). Of note, 
Slx5 was identified as a high-copy suppressor of a temperature-sen-
sitive SUMO protease mutant, ulp1ts (Xie et al., 2007).
STUbLs use SIMs to interact noncovalently with SUMO, SUMO 
chains, and sumoylated substrate proteins. A consensus SIM se-
quence consists of a hydrophobic core (V/I-X-V/I-V/I) that is often 
juxtaposed with a stretch of acidic and/or phosphorylated amino 
acids (Kerscher, 2007). Slx5 is the targeting subunit of the Slx5/Slx8 
STUbL and contains at least four SIMs, but only two are essential for 
the interaction with SUMO and the formation of nuclear Slx5 foci 
(Xie et al., 2007, 2010; Cook et al., 2009). Multiple SIMs in Slx5 are 
believed to increase the affinity of Slx5/Slx8 for SUMO chains or 
polysumoylated proteins. SIMs are not limited to STUbLs, and pro-
teins that otherwise lack affinity for each other may use SUMO to 
interact through SIMs. This can be useful for subcellular targeting 
and the formation of large protein complexes—for example, during 
the biogenesis of PML bodies (Lin et al., 2006; Shen et al., 2006). In 
addition, some proteins contain both SIMs and ubiquitin-interacting 
motifs, and it is believed that these proteins may be able to interact 
with hybrid SUMO–ubiquitin chains formed by STUbLs. For exam-
ple, hybrid SUMO–ubiquitin chains formed by Slx5/Slx8 and RNF4 
are recognized by yeast Ufd1 (the substrate-recruiting cofactor of 
the Cdc48p-Npl4p-Ufd1p complex) and mammalian Rap80 (a ubiq-
uitin-interacting motif containing protein with a role in the DNA 
damage response), respectively. Thus hybrid SUMO–ubiquitin 
chains serve as “coded keys” representing a SUMO-dependent sig-
nal that helps orchestrate DNA repair functions (Guzzo et al., 2012; 
Guzzo and Matunis, 2013; Nie et al., 2012).
Here we describe the results of a structure–function analysis of 
Slx5. In the course of this study we determined that Slx5 interacts 
with the mitotically regulated SUMO E3 ligase Siz1 in vitro and in 
vivo. Budding yeast cells exhibit a closed mitosis, and Siz1 is unusual 
in that it is exported from the intact nucleus at the onset of mitosis to 
sumoylate septins at the bud neck of dividing cells. Several observa-
tions now suggest that Siz1 is a cell cycle–dependent target of the 
Slx5/Slx8 STUbL. First, Slx5/Slx8 ubiquitylates a Siz1 construct in 
vitro. Second, we find that slx5∆ cells contain increased steady-state 
levels of phosphorylated and sumoylated Siz1 in vivo. Finally, Siz1 
protein that remains in the nucleus after the onset of mitosis is de-
graded in an Slx5-dependent manner. These data provide a first look 
into the cell cycle–dependent regulation of SUMO ligase activity via 
STUbLs.
activity of a dedicated cascade of Ubl-specific E1 (activating), E2 
(conjugating), and E3 (ligating) enzymes (reviewed by Kerscher 
et al., 2006). To ensure that the correct protein is modified with 
ubiquitin, ubiquitin E3 ligases recognize individual substrate pro-
teins (reviewed in Deshaies and Joazeiro, 2009). For the majority of 
sumoylation events, a consensus motif ψKXE/D (ψ being a large 
hydrophobic amino acid and X any residue) in the target protein 
appears sufficient for sumoylation via the E2 conjugating enzyme 
Ubc9 (Sampson et al., 2001). However, in the absence of sumoyla-
tion motifs or to enhance sumoylation on specific proteins, SUMO 
E3s are required. These include Siz1, Siz2, Mms21, and Zip3 in yeast 
(Johnson and Gupta, 2001; Zhao and Blobel, 2005; Cheng et al., 
2006; Takahashi et al., 2006).
Siz1 and Siz2 account for the majority of E3-mediated sumoyla-
tion in yeast. These E3 ligases have some overlapping substrates, 
whereas others are unique (Reindle et al., 2006). For example, the 
bud neck–localized septin proteins Cdc3, Cdc11, and Shs1 depend 
solely on Siz1 for their sumoylation (Johnson and Gupta, 2001; 
Takahashi et al., 2001a,b). Sumoylation of these septins requires that 
Siz1 be exported from the nucleus in mitosis, via the karyopherin 
Msn5, to associate with septins at the bud neck of dividing cells. 
Msn5 is known to transport phosphorylated cargoes, and the phos-
phorylation of Siz1, via an unknown kinase, may facilitate its export 
from the nucleus (Takahashi and Kikuchi, 2005; Takahashi et al., 
2008; Makhnevych et al., 2007). In msn5∆ cells Siz1 is not exported 
from the nucleus and septins remain unsumoylated (Makhnevych 
et al., 2007).
Both ubiquitin and SUMO can form chains on the targets they 
modify. Ubiquitin has seven lysines, and at least five of these (K6, 
K11, K29, K48, K63) can serve as conjugation sites for additional 
ubiquitin molecules (Wickliffe et al., 2009). In contrast, all SUMO 
variants, except SUMO1, form chains through lysines in their amino 
terminus. Yeast SUMO has three lysines (K11, K15, and K19), all cen-
tered on sumoylation consensus sites, that are required for SUMO-
chain formation (Bylebyl et al., 2003; Ulrich, 2008). SUMO chains 
accumulate due to heat shock, osmotic stress, and replicative stress 
(Vertegaal, 2010). As detailed later, the exact role of SUMO chains in 
the cellular stress response is not entirely clear. However, SUMO 
chains can also become ubiquitylated via SUMO-targeted ubiquitin 
ligases (STUbLs), and these branched Ubl structures may play an 
important role in protein degradation and signaling (Guzzo et al., 
2012; Guzzo and Matunis, 2013; Nie et al., 2012).
STUbLs, first functionally identified in yeasts, have given cre-
dence to a proteolytic role of SUMO. STUbLs are ubiquitin E3 li-
gases that can specifically target and bind SUMO chains or proteins 
modified with SUMO chains and facilitate their ubiquitylation, al-
though recent evidence suggests that STUbLs may not always re-
quire SUMO or SUMO chains to interact with their substrates (Xie 
et al., 2010). Members of this unusual family of ubiquitin ligases are 
exquisitely conserved and have been identified in yeasts, flies, frogs, 
fish, mice, and humans (reviewed by Prudden et al., 2007; Geoffroy 
and Hay, 2009; Praefcke et al., 2012). There are four STUbL proteins 
(Slx5, Slx8, Ris1, Rad18) in the budding yeast Saccharomyces cerevi-
siae, three in fission yeast Schizosaccharomyces pombe (Rfp1, Rfp2, 
and Slx8), and at least one in multicellular eukaryotes, including hu-
mans (RNF4; Wang et al., 2006; Sun et al., 2007; Uzunova et al., 
2007; Xie et al., 2007; Tatham et al., 2008; Mukhopadhyay et al., 
2010; Parker and Ulrich, 2012). Budding yeast Slx5 and Slx8 form a 
complex that plays an important role in the DNA damage response, 
genome maintenance, and proteasome-mediated degradation of 
specific transcriptional regulators. Included in a growing list of 
experimentally confirmed ubiquitylation targets of Slx5/Slx8 are the 
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Considering the important role of 
STUbLs in DNA repair and genome mainte-
nance, we asked whether particular domains 
of Slx5 are required for nuclear localization. 
Therefore we determined the localization of 
six carboxy-terminal (C1–C6) Slx5 trunca-
tions in yeast (Figure 1A). These Slx5 trunca-
tions differed by ∼100 amino acids (aa) in 
length, with one exception. The Slx5 con-
struct C6 was 50 aa in length and contained 
only SIM1 of Slx5 (Figure 1A). All green fluo-
rescent protein (GFP)–tagged Slx5 trunca-
tions and the full-length Slx5-GFP control 
(Cook et al., 2009) were expressed under 
control of the native Slx5 promoter from 
low-copy plasmids. Representative images 
of live yeast cells expressing GFP-tagged 
Slx5 truncations were recorded at early log 
phase (Figure 1B). Image analysis of our 
Slx5-GFP constructs revealed that the ab-
sence of the Slx5 RING domain (aa 490–620) 
and SIM5 (476–479) does not grossly affect 
nuclear localization and formation of nuclear 
foci (constructs C1 and C2; see Figure 1 leg-
end for incidence of foci). Of interest, a trun-
cation consisting only of the amino-terminal 
half of Slx5 (C3: 1–310) was still enriched in 
the nucleus. This nuclear localization was 
abruptly altered in a slightly shorter Slx5-
GFP truncation (C4: Slx5-GFP(1–207)). Slx5-
GFP(1–207) appeared to reside both in the 
cytoplasm and in the nucleus and lacked 
distinct foci. It is unlikely that the Slx5-
GFP(1–207) fusion protein simply leaked 
from the nucleus because this GFP-tagged 
Slx5 truncation is larger (57 kDa) than 
the defined molecular weight for passive 
nuclear diffusion (Shulga et al., 2000). 
As expected, constructs that were even 
smaller than Slx5(1–207)-GFP—C5(1–104) 
and C6(1–50)—also failed to be enriched in 
the nucleus.
We further investigated the functional 
relevance of the Slx5(207–310) domain. 
Fusion of Slx5(207–310) to GFP revealed 
that this domain, when expressed in wild-
type yeast cells, is involved in nuclear 
localization. Slx5(207–310)-GFP shows a 
diffuse nuclear enrichment with some 
residual cytosolic staining (Figure 1B, 
207–310). We were unable to identify a specific NLS in this do-
main but noticed that the overlapping region from amino acid 
188 to 260 was enriched in arginine residues. Therefore we gen-
erated an Slx5(∆188–260)-GFP construct and found that its nu-
clear localization was reduced, with a concomitant redistribution 
to the cytosol (Figure 1B). Image analysis revealed a significant 
reduction of nuclear localization (Kruskal–Wallis test, 109.3; 
df = 1; p < 0.001) for the Slx5(∆188–260)-GFP mutant. However, 
because nuclear localization of the deletion mutant is not 
completely abolished, we conclude that additional determinants 
of nuclear localization may reside in the carboxy terminus of 
Slx5.
RESULTS
Targeting of Slx5 depends on a nuclear-localization domain 
and SIMs
Slx5 is the targeting subunit of the heterodimeric Slx5/Slx8 STUbL 
complex in budding yeast. The Slx5 protein contains at least four 
SIMs (amino acids 24–158) and a carboxy-terminal RING domain 
(amino acids 490–620; Figure 1A; Mullen et al., 2001; Uzunova 
et al., 2007; Xie et al., 2007, 2010; Cook et al., 2009). We previ-
ously reported that SIMs in Slx5 are involved in the formation of 
nuclear foci, whereas the RING domain is required for substrate 
ubiquitylation by the Slx5/Slx8 heterodimer (Xie et al., 2007; Cook 
et al., 2009).
FIGURE 1: Targeting of Slx5 depends on a nuclear-localization domain and SIMs (A) Graphic 
depiction of six carboxy-terminal truncations (C1–C6) of Slx5. The length of each truncation 
construct is indicated by the scale above, with full-length Slx5 being 620 amino acids in length. 
Also indicated are previously identified SIMs and the RING domain (dark gray) of the full-length 
(WT) Slx5 protein, a small Slx5 domain (207–310) implicated in nuclear localization and 
dimerization, and a full-length Slx5 deletion construct lacking an arginine-rich region, ∆188–260. 
Point mutations in Sim1 and 2 are indicated as asterisks. (B) Subcellular localization of GFP-
tagged Slx5 truncations (C1–C6) indicated in A. Plasmids expressing GFP-tagged C1–C6 
constructs and the Slx5 domain (207–310) were transformed into yeast cells to determine their 
subcellular localization in comparison to full-length WT Slx5-GFP. Notice nuclear Slx5 foci present 
in C1 (foci 32 ± 7.3%, n = 352), C2 (foci 42.5 ± 3.72%, n = 271), and C3 (foci 23 ± 10.5%, n = 232). 
Constructs C4–C6 are distributed throughout the cells, with an additional enrichment of C4 at 
the bud neck (yellow arrow) of dividing cells (bud neck localization 11.5 ± 1.29%, n = 374). 
GFP-tagged Slx5(207–310) is enriched in the nucleus (red arrows), suggesting that this domain is 
important for nuclear localization of Slx5. Reciprocally, an overlapping construct, Slx5(∆188–260)-
GFP, is redistributed between the nucleus and the cytosol. The nuclear Slx5-GFP signal averaged 
64.5 ± 4.9% (n = 85 nuclei, red arrows, bottom) compared with 56 ± 2.3% (n = 84 nuclei, blue 
arrows) in the Slx5(∆188-260)-GFP mutant (Kruskal–Wallis test, 109.3; df = 1; p < 0.001). Note 
that both constructs in the bottom also contain point mutations in Sim1 and Sim2 (indicated by 
asterisks) to ensure that the localization was unbiased of association with SUMO and sumoylated 
proteins in the nucleus and the cytosol. Furthermore, the localization of both constructs in the 
bottom was evaluated in an slx5/slx8 double mutant to prevent association with endogenous 
Slx5 and Slx8. n, number of log-phase cells imaged and analyzed ± SD.
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A truncation of Slx5 is enriched at the bud neck 
of dividing cells
Careful analysis of the carboxy-terminal truncations of Slx5 revealed 
that Slx5-GFP(1–207) not only accumulated in the cytoplasm but also 
was visibly enriched at the bud neck of dividing cells (11.5 ± 1.29%, 
n = 374; Figure 1B). We reasoned that this localization was due to the 
SIM-mediated association of Slx5(1–207)-GFP with sumoylated sep-
tins at the bud neck. Septins, including Cdc3, Cdc10, Cdc11, Cdc12, 
and Shs1, form a filamentous ring structure at the bud neck between 
mother and daughter cell of dividing yeast (Douglas et al., 2005; Cao 
et al., 2009). SUMO modification of Cdc3, Cdc11, and Shs1 in mitosis 
plays an important role in septin ring dynamics (Johnson and Blobel, 
1999) but may also serve to recruit SIM-containing and SUMO-bind-
ing proteins in mitosis (Kusch et al., 2002; Elmore et al., 2011).
To test whether Slx5(1–207) colocalized with individual septins, 
we chromosomally tagged CDC3 with the gene encoding the yel-
low fluorescent protein (YFP; YOK1325). This CDC3-YFP strain 
was then transformed with a plasmid encoding Slx5(1–207) fused 
to the gene encoding the cyan fluorescent protein (CFP; strain 
YOK1364). Live imaging of G2/M-arrested cells revealed that both 
Cdc3-YFP and Slx5(1–207)-CFP fusion proteins were expressed and 
colocalized to septin rings in the majority (∼80%) of large-budded 
cells (Figure 2A). In logarithmically growing cells colocalization of 
Slx5(1–207)-CFP and Cdc3-YFP to one or two septin rings was ob-
served (∼20%). However, as expected, the colocalization was limited 
to large-budded cells in mitosis.
Next we tested our hypothesis that the localization of Slx5(1–
207)-GFP to the septin ring was dependent on SUMO. We examined 
the ability of Slx5(1–207) with SIM1/2 mutations (25-AAA-27 and 93-
ATAA-96) to bind to septins. We previously showed that SIM1 and 
SIM2 play a critical role in the formation of Slx5 nuclear foci and 
SUMO binding (Xie et al., 2007; Cook et al. 2009). The Slx5(1-207) 
SIM1/2 mutant and a control plasmid with intact SIMs were trans-
formed into a wild-type strain, and G2/M-arrested cells were exam-
ined. The Slx5(1–207) construct was localized throughout the cell but 
was also visually enriched at the bud neck of 65% of G2/M-arrested 
cells (Figure 2B, top left). Of note, the enrichment of the Slx5(1–207) 
SIM1/2 mutant at septins was barely visible, and only a few cells 
displayed residual staining at the bud neck (Figure 2B, top right). 
Next we expressed Slx5(1–207)-GFP in a strain that is unable to form 
polySUMO chains (smt3-R11,15,19; Bylebyl et al., 2003). Here we 
found that Slx5(1–207) septin localization was reduced to ∼27% but 
not eliminated in smt3(R11,15,19) cells (Figure 2B, bottom left).
Finally, we also tested a deletion of the SUMO E3 ligase gene 
SIZ1, which is required for the sumoylation of bud neck–localized 
septins in mitosis (Johnson and Blobel, 1999). Consistent with the 
foregoing data, Slx5(1–207)-GFP localization to septins was greatly 
reduced or absent in siz1∆ cells (Figure 2B, bottom right). In sum-
mary, these data suggest that the bud neck localization of the cyto-
solic Slx5(1–207) truncation depends on both the cell cycle–specific 
sumoylation of septins and the SIMs in Slx5. However, we cannot 
exclude the possibility that Siz1 recruits this construct to the bud 
neck. Even though we found no evidence that septins are physio-
logical targets of this STUbL subunit, our observations provide a vi-
sual in vivo assay for SUMO-dependent targeting of Slx5 to a highly 
sumoylated target, the septins (Elmore et al., 2011).
The STUbL subunit Slx5 has distinct and separate domains 
for interaction with Slx8, Slx5, and SUMO
The results obtained in our localization studies (Figure 1B) raised the 
possibility that individual domains of Slx5 may functionally interact 
FIGURE 2: A Slx5 truncation containing four SIMs but lacking the 
potential nuclear localization domain (207–310) is enriched at the 
septin ring of G2/M-arrested cells. (A) Cells expressing the YFP-
tagged septin protein Cdc3-YFP (YOK1325) were transformed with 
SLX5(1-207)-CFP (compare construct C4; BOK 507) and then 
arrested in G2/M before microscopic analysis in live cells. 
Slx5(1-207)-CFP was present diffusely throughout the cells but was 
visibly enriched at the bud neck of G2/M-arrested cells 
(pseudocolored in green), where it colocalized with Cdc3-YFP at the 
septin ring (pseudocolored in red). Colocalization was observed in 
∼80% of cells showing expression of both constructs. (B) The bud 
neck localization of SLX5(1–207) depends on SIMs and the SUMO 
ligase Siz1. SLX5(1–207)-GFP (BOK505) and a mutant lacking SIM1 
and 2 (1–207(∆sim1/2)) were transformed into yeast cells to 
determine the requirement for bud neck localization of each 
construct in G2/M-arrested cells (top left and right). Slx5(1-207)-GFP 
septin enriched at the bud neck of G2/M-arrested cells was 
observed in 65 ± 15% of WT cells (n = 162, white arrows). In 
contrast, septin localization of Slx5(1–207(∆sim1/2)) was greatly 
reduced or absent (n = 108, yellow arrows). The localization of 
Slx5(1–207)-GFP was then analyzed in a strain expressing a mutant 
SUMO protein that fails to form chains (bottom left, smt3(R11,15,19) 
or strains deleted for the SUMO ligase Siz1, which sumoylates 
septins (bottom right, siz1∆). Note that bud neck localization was 
still observed in 27.4 ± 14.9% of smt3(R11,15,19) cells (n = 338) but 
not in the siz1∆ mutant (yellow arrowhead). n, number of 
G2/M-arrested cells imaged and analyzed.
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found that a full-length Slx5 bait can also in-
teract with other Slx5 prey proteins, raising 
the possibility that this STUbL subunit, simi-
lar to its human orthologue RNF4, may ho-
modimerize (Liew et al., 2010).
Analysis of the Slx5 bait truncations re-
veals that at least one SIM (SIM1: 24VILI27) 
is required for interaction with yeast SUMO 
(Smt3; Figure 3: C6 with SUMO). In contrast, 
the interaction of Slx5 bait with other Slx5 
prey proteins was independent of SIM1, 2, 
3, and 4 and dependent on a novel domain 
between amino acids 207 and 310 (Figure 3: 
N4 and C3 with SLX5). Of interest, Slx5(207–
310) overlapped with the domain involved 
in nuclear localization of Slx5 (Figure 1B, red 
arrow). One possible explanation for this 
finding is that homodimerization is required 
for nuclear import or nuclear retention of 
Slx5. Several examples of proteins that re-
quire dimerization for nuclear import exist 
(Fryrear et al., 2009; Hayes et al., 2009). 
However, dimerization of Slx5 is a possibility 
that requires further investigation.
The interaction of Slx5 with Slx8 was 
more complex. One SLX5 truncation (C1), 
retaining only two cysteine residues (Cys-
494 and Cys-497) of the RING domain, 
showed a reproducible interaction with Slx8. 
Surprisingly, none of the Slx5 amino-termi-
nal deletions (N1–N6) scored positive in our 
interaction assay with Slx8. This suggests 
that the amino terminus but not the entire 
RING domain of Slx5 is required for interac-
tion with Slx8. To further investigate how 
Slx5 interacts with Slx8, we used a full-length 
Slx5 bait construct lacking both SIM1 and 
SIM2 (Slx5(∆sim1/2); Xie et al., 2007). Full-
length Slx8 prey and full-length Slx5(∆sim1/2) 
bait were cotransformed into the two-hybrid 
assay strain. As a control, both constructs 
were also tested against SMT3 and SLX5 
constructs. In accordance with the forego-
ing data, the Slx5(∆sim1/2) mutant inter-
acted strongly with Slx5, failed to interact 
with Smt3, and was greatly reduced in its 
interaction with Slx8 (Supplemental Figure 
S1). Therefore both SIMs and the RING do-
main of Slx5 may be important for the interaction with Slx8. In sum-
mary, our two-hybrid fine-structure mapping defines four distinct 
Slx5 domains required for interaction with Smt3 (aa 1–207), Slx5 (aa 
207–310), and Slx8 (aa 1–50 and 490–620).
The STUbL subunit Slx5 forms a complex with the SUMO 
ligase Siz1
Because Slx5(1–207) localized to septin rings in a SUMO-targeting 
assay, we decided to test its interaction with potential sumoylated 
substrate proteins at the bud neck. Despite its enrichment at the 
septin ring, Slx5(1–207) failed to interact with the septins Cdc3 and 
Cdc11 (unpublished data). However, Slx5 interacted in a two-hybrid 
assay with a known septin-interacting protein, the SUMO E3 ligase 
Siz1 (Figure 3B, bottom right). Siz1 resides in the nucleus but 
with different proteins such as sumoylated substrates, other STUbL 
subunits, or nuclear transport factors.
To test this hypothesis, we initially focused on the interaction of 
Slx5 with two known interactors, SUMO and Slx8 (Ii et al., 2007; Xie 
et al., 2007; Mullen and Brill, 2008). Specifically, we delineated the 
interaction domains of Slx5 using a collection of six amino-terminal 
(N1–N6) and six carboxy-terminal Slx5 bait truncations (C1–C6; 
Figure 3A). Full-length or truncated Slx5 bait constructs (Gal4-BD 
fusions) were cotransformed with the appropriate prey constructs 
(Gal4-AD fusion of Slx8 or SUMO) into a two-hybrid reporter strain 
(AH109). Bait/prey interactions were scored as growth of double 
transformants on growth media lacking adenine and/or histidine 
(Figure 3B). Our data confirmed that full-length Slx5 interacts with 
SUMO and Slx8 (Figure 3B, bottom). Furthermore, we unexpectedly 
FIGURE 3: Slx5 uses distinct domains to interact with Slx8, Slx5, yeast SUMO (Smt3), and Siz1. 
(A) Graphic depiction of six carboxy-terminal deletions (C1–C6) and six amino-terminal deletions 
(N1–N6) of Slx5. The length of each truncation construct is indicated by the scale above, with 
full-length Slx5 being 620 amino acids in length. Also indicated are previously identified SIMs 
and the RING domain (dark gray) of the full-length (WT) Slx5 protein. (B) Analysis of two-hybrid 
interaction of WT Slx5 and various Slx5 truncations (C & N). Duplicate spots of yeast cell colony 
patches indicate two-hybrid interactions of Slx5 with full-length Slx5, Slx8, Smt3, and Siz1 
(bottom). Interactions of Slx5, Slx8, Smt3, and Siz1 with individual Slx5 truncations (amino-
terminal, N1–N6; carboxy-terminal, C1–C6) correspond to the Slx5 truncations in A (see arrows). 
Refer to Materials and Methods for details of the two-hybrid analysis. Note that the domain 
encompassing amino acids 207–310 of Slx5 is required for interaction with full-length Slx5 and 
that the interaction pattern of Slx5 with SUMO (Smt3) mirrors that with Siz1. (C) Graphic 
depiction of Slx5 interaction derived from our structure–function analysis in Figures 1 and 2 and 
this figure. Depicted are Slx5 amino acids 1–620 (increments indicate our constructs), with 
SIM1–5 and the RING domain, an arginine-rich domain that may be involved in nuclear 
localization that overlaps the Slx5 interaction domain and is marked with a gray bar.
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becomes enriched on the septin ring during the G2/M phase of the 
cell cycle, presumably to sumoylate septins. Accordingly, in the ab-
sence of Siz1, septins, including Cdc3 and Cdc11, fail to be sumoy-
lated (Johnson and Gupta, 2001).
We decided to investigate which domain of Slx5 was required for 
the interaction with Siz1. Using our panel of 12 Slx5 two-hybrid 
baits, we found that interaction with Siz1 requires at least two SIMs 
(SIM1 and 2) in Slx5 (Figure 3B, construct C5). The observed interac-
tion closely mirrors the pattern we observed for interaction between 
our Slx5 bait constructs and SUMO. This suggests that the interac-
tion of Slx5 with Siz1 may depend on SUMO and possibly sumoyla-
tion of Siz1. Indeed, when we tested the interaction of Siz1 with the 
Slx5(∆sim1/2) or a Siz1-RING mutant (Siz1(C377S H379A)), we no longer 
observed the interaction (Supplemental Figure S1).
To confirm our finding of the Slx5–Siz1 interaction, we tested 
whether both proteins could interact in vitro and in vivo. First we 
probed the ability of recombinant Slx5 and Slx8 to interact with a 
purified truncation of Siz1 (Siz1(∆440)). Siz1(∆440) lacks the carboxy-
terminal 439 amino acids but retains its SUMO ligase activity and 
can be stably expressed in bacterial and yeast cells (Takahashi and 
Kikuchi, 2005). To accomplish this task, we mixed bacterial protein 
extracts containing overexpressed maltose-binding protein (MBP) 
fusions of Slx5 or Slx8 (Xie et al., 2007) with bacterial extracts con-
taining overexpressed, T7-tagged Siz1(∆440). Extracts were then 
passed over amylose affinity resins. We observed that Siz1(∆440) 
bound to the amylose affinity resins only when Slx5-MBP or Slx8-
MBP was also bound (Figure 4A, lanes 1 and 2). This suggests that 
recombinant Siz1(∆440) can interact with both Slx5 and Slx8 in 
vitro.
Second, we constructed a yeast strain in which glutathione 
S-transferase (GST)–tagged Slx5 and V5-tagged Siz1(∆440) were 
both expressed from plasmids under control of the strong inducible 
Gal promoter. From lysates of this strain, Slx5-GST was affinity puri-
fied on glutathione agarose, and copurifying Siz1(∆440)-V5 was de-
tected after immunoblotting with an anti-V5 antibody (Figure 4B, 
lanes 5 and 7). In contrast, Siz1(∆440) expressed in the absence of 
Slx5-GST did not bind to glutathione agarose (Figure 4B, compare 
lanes 3 [flowthrough] and 6 [elution]). In summary, we conclude that 
the SUMO ligase Siz1 can form a complex with the STUbL-targeting 
subunit Slx5 in yeast cells.
Siz1 is an in vitro and in vivo ubiquitylation substrate 
of Slx5/Slx8
The evidence presented here suggests that Siz1 forms a complex 
with Slx5 in living cells. Therefore we tested Siz1 as a candidate 
substrate for the Slx5/Slx8 STUbL. We purified the Siz1(∆440) trun-
cation and combined it with recombinant Slx5 and Slx8 in an in vitro 
ubiquitylation reaction (see Materials and Methods). In this assay we 
found Siz1(∆440) to be ubiquitylated in an ATP-, E2-, and E3 (Slx5/
Slx8)-dependent manner (Figure 5A). Addition of an amino-terminal 
SUMO moiety to Siz1(∆440), forming SUMO-Siz1(∆440), did not 
dramatically stimulate the ubiquitylation of this fusion protein (un-
published data). This is in accordance with the previous finding that, 
at least in vitro, SUMO modification is not an absolute requirement 
for the specific ubiquitylation by Slx5/Slx8 (Xie et al., 2007, 2010). 
Another interesting observation is that Siz1 is robustly ubiquitylated 
by Slx5/Slx8, but only with two or three ubiquitin moieties. One pos-
sibility is that more extensive ubiquitylation of Siz1 can take place in 
vivo.
Consequently, we tested whether Siz1 is also ubiquitylated in 
vivo. Briefly, we used a ubiquitin-shift assay to compare adducts of 
yeast-expressed Siz1∆440, modified either with myc-tagged or 
FIGURE 4: The STUbL subunit Slx5 forms a complex with the SUMO 
ligase Siz1. (A) Slx5 and Slx8 interact with Siz1 in vitro. Recombinant 
MBP-Slx5, MBP-Slx8, and T7-tagged Siz1(∆440)-His6 (BOK 500, BOK 
501, BOK 758) were produced in bacterial cultures. Then 50 OD units 
of induced Slx5 and Slx8 cultures were individually combined with 50 
OD units of Siz1(∆440). Siz1(∆440), 50 OD units, served as a negative 
control. Whole-cell extracts from the combined or control cultures 
(Input) were clarified by centrifugation and passed over a column 
containing amylose resin. After extensive washing, eluates (elute) 
corresponding to ∼1 OD unit of input material were analyzed with an 
anti-T7 antibody (left). Simply Blue staining (Life Technologies) of a gel 
with duplicate samples (1–3) reveals the bound recombinant Slx5 
(∼125 kDa) and Slx8 (∼90 kDa) but not the control Siz1(∆440) protein 
(∼60 kDa) on the amylose resin (right). (B) Slx5 interacts with Siz1 in 
vivo. We harvested 20 OD units of cells from strains overexpressing 
GST-Slx5 only (YOK 2507), GST-Slx5 and Siz1(∆440)-HA (YOK 2509), or 
Siz1(∆440)-HA only (YOK 2508) and prepared protein extracts by 
bead-beating. Clarified extracts were passed over individual 
glutathione agarose columns, and bound proteins were eluted after 
extensive washing with 10 mM reduced glutathione (lanes 4–6) or 
sample buffer (lanes 7 and 8). Also shown are input material (0.3% of 
total OD harvested) for strain YOK 2509 (lane 1) and flowthrough for 
strains YOK 2509 and YOK 2508 (lanes 2 and 3). “Elute” loaded 
corresponds to 0.45% of total OD harvested. Presence or absence of 
Slx5-GST and Siz1(∆440)-HA in each sample is indicated as + or –, 
respectively. All samples were separated by SDS–PAGE, and individual 
proteins were detected after Western blotting using anti-GST or 
anti-HA antibodies as indicated. Note that Siz1(∆440) is only eluted 
when Slx5-GST is bound to the affinity resin (lanes 5 and 7), indicating 
an in vivo interaction between the two proteins.
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action, we determined the steady-state level of chromosomally ex-
pressed Siz1 protein in wild-type (WT) and slx5∆ strains. Briefly, an 
slx5∆ strain expressing myc-tagged Siz1 was backcrossed to an 
isogenic WT strain. As expected, in meiotic progeny that expressed 
myc-tagged Siz1, the protein was detected as a distinctive band 
running just below the 150-kDa marker after Western blotting with 
a myc-specific antibody (Figure 6A, tetrad 7, spores 1 and 4, and 
tetrad 10, spores 3 and 4). Surprisingly, the steady-state levels of the 
Siz1 protein in slx5∆ strains (Figure 6A, tetrad 7, spore 4, and tetrad 
10, spore 3) were markedly enhanced in comparison to the WT 
(tetrad 7, spore 1, and tetrad 10, spore 4). In addition, increased 
levels of high–molecular weight adducts of Siz1-myc, consistent 
with its sumoylation, were visible in the slx5∆ strain. Siz1 was previ-
ously shown to be autosumoylated in vivo, and these data are con-
sistent with our analysis of in vivo Siz1 sumoylation in a SUMO shift 
assay and after metal affinity chromatography (Supplemental Figure 
S2; Takahashi and Kikuchi, 2005).
It is also well established that Siz1 is phosphorylated by an un-
known kinase, and, as described earlier, this modification may be 
linked to its nuclear export before septin sumoylation (Johnson and 
untagged ubiquitin G76A (Ubi(G76A)). Ubi(G76A) can still be conjugated 
to proteins but is resistant to deubiquitylation, making it a useful 
tool for studying potential ubiquitylation targets such as Siz1∆440 
(Hodgins et al., 1992). Whole-cell extracts and immunoprecipita-
tions show differentially shifted Siz1∆440 adducts, indicating that 
the protein is ubiquitylated in vivo (Figure 5B, left and middle). 
These adducts resembled those seen in the in vitro assays. Using 
the same technique, we also showed that ubiquitylation of Siz1 is 
dramatically reduced in an slx5∆ mutant (Figure 5B, right). Therefore 
we conclude that the Slx5/Slx8 STUbL can ubiquitylate Siz1∆440 in 
vitro and in vivo.
Slx5 affects the steady-state level, phosphorylation, 
and sumoylation of Siz1 in vivo
Our data are consistent with a role for Slx5 and STUbL-mediated 
regulation of Siz1. To address the functional relevance of this inter-
FIGURE 6: Slx5 affects the steady-state level and phosphorylation 
status of Siz1. (A) Altered steady-state level of Siz1 in slx5∆ cells. A 
heterozygous diploid SLX5/slx5∆ SIZ1/SIZ1-myc/HIS3 strain was 
sporulated, and the resulting haploid progeny of two tetrads (tetrad 7 
[YOK 2279-2282] and tetrad 10 [YOK 2283-2286]) were genotyped 
(WT and ∆). Proteins were extracted from the indicated haploid 
strains to determine the steady-state levels of the myc-tagged Siz1 
protein in WT and slx5∆ progeny. An anti-myc antibody was used to 
detect Siz1 on immunoblots of SDS–PAGE–separated proteins. Note 
the increased steady-state levels and modifications of Siz1 in slx5∆ 
strains (tetrad 7-4 and tetrad 10-3) in comparison to Siz1 levels in WT 
strains (tetrad 7-1 and tetrad 10-4). Equal protein loading of all 
extracts was determined using an anti-Pgk1 antibody. (B) Siz1 is 
differentially phosphorylated under various growth conditions in WT 
(YOK 2286) vs. slx5∆ (YOK 2264) cells. Log, untreated, logarithmically 
growing cells; HU, hydroxyurea treatment to arrest in S phase; NZ, 
nocodazole treatment to arrest in G2/M. Endogenous, myc-tagged 
Siz1 protein in WT and slx5∆ cells was detected after immunoblotting 
of SDS–PAGE–separated proteins using an anti-myc antibody. Single 
and double asterisks denote differentially phosphorylated forms of 
Siz1. Equal protein loading of all extracts was determined using an 
anti-Pgk1 antibody.
FIGURE 5: Ubiquitylation of Siz1 by Slx5/Slx8 in vitro. In vitro STUbL 
ubiquitylation reactions, detailed in Materials and Methods, were 
assembled with the recombinant proteins E1 (Uba1), E2 (Ubc4), and 
E3 (Slx5 and Slx8), ATP, and substrate (SUB, Siz1(∆440)). As controls, 
individual components were omitted from the indicated reactions in 
lanes 1–4 (–ATP, –E2, –E3, –SUB). After incubation, the substrate 
protein in all reactions was analyzed by immunoblotting with an 
anti-T7 antibody. Lane 5 contains the complete reaction (ALL) and 
reveals STUbL-dependent ubiquitylation of Siz1 (Siz1(∆440)-(Ub)n 
(lane 5). Molecular weights in kilodaltons are indicated on the left. 
(B) Slx5-dependent ubiquitylation of Siz1∆440 in vivo. Siz1∆440 was 
expressed in yeast cells (WT or slx5∆), and a ubiquitin-shift assay was 
used to compare adducts of Siz1∆440 modified either with myc-
tagged or untagged ubiquitin G76A (+ or –). Siz1∆440 was detected 
in whole-cell TCA extracts (WCE) or after immunoprecipitation with 
anti-V5 agarose (IP). Differentially shifted ubiquitylated adducts of 
Siz1∆440 are indicated with white and gray arrows (top). Bottom, 
Western blots of the same samples probed with an anti-myc antibody 
to reveal shifted bands that correspond to myc-tagged ubiquitin.
8 | J. W. Westerbeck et al. Molecular Biology of the Cell
cycloheximide chase time course, whereas all forms of Siz1 were 
rapidly degraded in the msn5∆ mutant.
Whether phosphorylation is solely required for Siz1’s nuclear ex-
port, precedes its sumoylation, or promotes other aspects of Siz1 
function is not yet clear. Of importance, our data reveal for the first 
time the functional interplay between SUMO E3 ligases and SUMO-
targeted ubiquitin ligases. In summary, this STUbL-dependent regu-
lation of nuclear localized Siz1 (see model in Figure 7D) may work in 
cooperation with other pathways to prevent the accumulation of 
specific nuclear SUMO conjugates that interfere with cell cycle pro-
gression or other vital processes.
DISCUSSION
We conducted an extensive structure–function analysis of the yeast 
STUbL subunit Slx5. Our data suggest that Slx5 consists of distinct 
and partially overlapping domains involved in its self-association 
and its interactions with Slx8 and yeast SUMO. We also began the 
functional dissection of a novel Slx5 interactor and STUbL target, 
the SUMO E3 ligase Siz1.
In our structure–function analysis of Slx5 we identified a 
new domain with an apparent role in nuclear localization of this 
STUbL subunit. Specifically, we observed that a GFP-tagged frag-
ment of Slx5, Slx5(207–310), is enriched in the nucleus (Figure 1). 
Of importance, Slx5(207–310) contains an arginine-rich region 
(207–RRIAERQRR–215), and similar features in other proteins have 
been implicated in protein dimerization, nuclear transport, interac-
tion with SH3 domain–containing proteins, and recognition of RNA 
hairpins (Hibbard and Sandri-Goldin, 1995; Fagerlund et al., 2002; 
Barylko et al., 2010). A conserved arginine-rich region has also 
been described in the human STUbL orthologue RNF4, and it has 
been suggested that this domain may be involved in detecting 
ATM-phosphorylated proteins (Kuo et al., 2012). Using a second 
construct that removes additional residues of the arginine cluster, 
Slx5(∆189–260), we find reduced nuclear localization. Therefore, 
based on our data, it is possible that this domain of the STUbL 
subunit Slx5 is somehow involved in nuclear localization or reten-
tion. It is important to note that the same domain is also required 
for the two-hybrid interaction of Slx5 with other Slx5 molecules. 
However, the functional relevance of this interaction requires fur-
ther investigation.
Unlike Slx5, Siz1 shows a cell cycle–dependent localization pat-
tern. Nuclear-localized Siz1 becomes phosphorylated at G2/M, is 
concomitantly exported, and then associates with septins at the bud 
neck of dividing cells (Johnson and Gupta, 2001). Elegant work by 
Makhnevych et al. (2007) showed that Msn5, a karyopherin that 
transports phosphorylated cargoes, is involved in nuclear export of 
Siz1 and that this export is required for septin sumoylation. There-
fore Siz1 may contain a nuclear export signal that depends on phos-
phorylation to be recognized by Msn5 (for comparison see DeVit 
and Johnston, 1999). Of interest, our work raises the possibility that 
Siz1 phosphorylation may also be a prelude to STUbL-mediated 
degradation, and we are exploring this possibility. The mammalian 
Siz1 orthologue PIAS1, which is phosphorylated by casein kinase 2, 
was recently found to contain a phosphoregulated SIM module. 
This phosphoregulated SIM does not appear to affect the sumoyla-
tion or turnover of PIAS1 but is required to modulate the activity of 
specific transcription factors (Stehmeier and Muller, 2009). A bona 
fide SIM also exists at position 484–491 of Siz1, but we have not yet 
determined whether it constitutes a phosphoregulated SIM module 
(Uzunova et al., 2007).
One of the most intriguing implications of this work is that 
STUbLs can regulate an important SUMO E3 ligase. In vitro and in 
Gupta, 2001; Makhnevych et al., 2007). Therefore we also investi-
gated the phosphorylation status of Siz1 in slx5∆ and WT cells. First 
we observed the phosphorylation of Siz1 in both slx5∆ cells and WT 
cells when cells were logarithmically grown, arrested in S phase with 
hydroxyurea (HU), or arrested in G2/M with nocodazole (Figure 6B). 
We confirmed the phosphorylation of Siz1 on Phos-tag gels (Wako 
Pure Chemicals Industries, Osaka, Japan), which further separated 
phosphorylated and unphosphorylated forms of the protein. In our 
analysis we found that the levels of both unphosphorylated and two 
discernible forms of phosphorylated Siz1 were markedly enhanced 
in slx5∆ cells. The effect of slx5∆ was less pronounced after HU and 
nocodazole treatment, with almost complete phosphorylation of 
Siz1 in nocodazole-arrested slx5∆ and WT cells.
PIAS1, an orthologue of Siz1 in mammalian cells, is phosphory-
lated by casein kinase 2 (Stehmeier and Muller, 2009). However, in 
our experiments deletion of CKB1, the nonessential β regulatory 
subunit of casein kinase 2 in budding yeast, did not appear to affect 
the phosphorylation status of Siz1 (unpublished data). In summary, 
our data reveal that the steady-state levels of both phosphorylated 
and unphosphorylated Siz1 are increased in slx5∆ cells and that cell 
cycle–dependent phosphorylation of Siz1 may somehow be in-
volved in its regulation.
Slx5 is required to modulate the levels of Siz1 in the nucleus
We devised and tested a model to understand the functional inter-
action of Slx5 with Siz1 during mitosis. This model takes into ac-
count that nuclear export and septin ring localization of Siz1 requires 
the karyopherin Msn5 and that in an msn5∆ mutant Siz1 accumu-
lates in the nucleus, most likely in its phosphorylated form (Johnson 
and Gupta, 2001; Makhnevych et al., 2007). We reasoned that nu-
clear retention of Siz1 could make it a substrate of the yeast Slx5/
Slx8 STUbL. Therefore we asked what would happen when nuclear 
egress of the Siz1 protein is prevented in msn5∆ cells.
First, we observed GFP-tagged Siz1 in wild-type cells and com-
pared it to slx5∆, msn5∆, and the msn5∆slx5∆ double mutant in 
logarithmically growing and G2/M-arrested cells. Consistent with 
previous results, Siz1-GFP is a nuclear protein but relocalizes to the 
septin ring of G2/M-arrested wild-type cells (Figure 7A). We ob-
served a similar localization in slx5∆ cells even though septin local-
ization was reduced by ∼20%. However, in both the msn5∆ and the 
msn5∆slx5∆ mutant, Siz1 was retained in the nucleus and could not 
be detected at the septin ring. Of note, nuclear Siz1-GFP levels in 
the msn5∆slx5∆ strain were considerably more pronounced than in 
msn5∆ cell. The Siz1-GFP signal in the nucleus of msn5∆ cells aver-
aged 60.1 ± 5.9% (n = 62 nuclei) compared with 70.6 ± 3.5% (n = 86 
nuclei) in the msn5∆slx5∆ strain. These values represent a significant 
increase of nuclear enrichment (Kruskal–Wallis test, 81.3; df = 1; 
p < 0.001) in the absence of Slx5. This observation is consistent with 
the accumulation of Siz1 in slx5∆ mutants and prompted us to fur-
ther examine Siz1 levels in these mutants.
To confirm our observation, we performed a cycloheximide 
chase of Siz1 in mitotically arrested WT and msn5∆ cells. Indeed, we 
found that the half-life of Siz1 was dramatically reduced in the msn5∆ 
strain, with little endogenous Siz1 remaining after 60 min (Figure 7B). 
In comparison, both phosphorylated and nonphosphorylated forms 
of Siz1 were only slightly modulated in the WT strain. Finally, to 
show that nuclear accumulated Siz1 is indeed an in vivo STUbL tar-
get once the cell enters mitosis, we performed a cycloheximide 
chase of Siz1 in a msn5∆slx5∆ strain. Consistent with our prediction, 
Siz1 was stabilized in the slx5∆msn5∆ double mutant but not the 
msn5∆ mutant (Figure 7C). Furthermore, Siz1 sumoylation in the 
slx5∆msn5∆ double mutant was maintained through the entire 
Volume 25 January 1, 2014 Cross-talk of ubiquitin and SUMO ligases | 9 
vivo we detect robust ubiquitylation of a 
truncated Siz1 construct, albeit only with 
monoubiquitin and diubiquitin (Figure 5A). 
Similar to other STUbL substrates, our in 
vitro modification was also not dependent 
on prior sumoylation of Siz1 (Xie et al., 2007, 
2010). The same truncated Siz1 construct is 
also ubiquitylated in vivo, and this modifica-
tion depends on SLX5 (Figure 5B). In vivo, 
sumoylation may be a prerequisite, because 
our preliminary experiments suggest that a 
RING mutant of this Siz1(Siz1(C377S H379A)) 
truncation fails to be ubiquitylated (N.P. and 
O.K., unpublished observations). Ultimately 
our data suggest that nuclear-localized 
Siz1 interacts with Slx5, is degraded in a 
FIGURE 7: Slx5 modulates the levels of Siz1 in the nucleus. (A) WT (YOK2738), slx5∆ (YOK2751), 
msn5∆ (YOK2624), and msn5∆slx5∆ (YOK2735) strains expressing Siz1-GFP as the only copy of 
this SUMO ligase were imaged during logarithmic growth (log; left) or after nocodazole-induced 
G2/M arrest (Noc; right). The localization of Siz1-GFP at septins is indicated with yellow arrows, 
and the localization of nuclei in msn5∆ and msn5∆slx5∆ strains is indicated with white 
arrowheads. (B) Siz1 is rapidly degraded in an msn5∆ mutant. Isogenic WT (YOK 2397) and 
msn5∆ (YOK 2514) strains expressing endogenous full-length Siz1-myc were grown overnight in 
yeast extract/peptone/dextrose (YPD) medium. Cells in logarithmically grown cultures were 
arrested with nocodazole. G2/M-arrested cells, 10 OD units, were pelleted, washed, and 
resuspended in fresh YPD medium without 
nocodazole containing 25 μg/ml 
cycloheximide. Subsequently, protein 
extracts of 2.5 OD units of cells were 
prepared at the indicated time points (0, 10, 
30, 60 min) before Western blotting to detect 
Siz1-myc. Siz1 levels were normalized against 
the Pgk1 loading control and graphed on the 
right. (C) A deletion of SLX5 stabilizes Siz1 in 
an msn5∆ mutant. Isogenic msn5∆ and 
msn5∆slx5∆ strains expressing Siz1-myc from 
LEU2/CEN plasmid pRS315 were grown 
overnight in selective media. Cells in 
logarithmically grown cultures were arrested 
with nocodazole and benomyl. G2/M-arrested 
cells, 22 OD units, were pelleted, washed, 
and resuspended in fresh YPD medium 
without nocodazole containing 25 μg/ml 
cycloheximide. Subsequently, protein 
extracts of 2 OD units of cells were prepared 
at the indicated time points (0, 40, 60, 90, 
120 min) before Western blotting to detect 
Siz1-myc and Pgk1 proteins. The first two 
lanes, msn5∆ (log) and msn5∆slx5∆ (log), are 
overloaded to show SUMO adducts of Siz1 in 
these strains. Siz1 levels were normalized 
against the Pgk1 loading control and 
graphed on the right. Siz1 protein levels, 
normalized to the Pgk1 control, were 
determined using a C-DiGit Western blot 
scanner (Li-COR, Lincoln, NE) and Image 
Studio software (Li-COR) and are shown 
below each time point. (D) Model of a STUbL-
dependent nuclear degradation pathway of 
sumoylated Siz1. At the onset of mitosis 
nuclear Siz1 becomes autosumoylated (green 
circles) and phosphorylated (p) via an 
unknown kinase. Phosphorylated Siz1 may be 
subject to Msn5-mediated nuclear export to 
facilitate septin sumoylation in the cytosol. 
Sumoylated Siz1 that remains in the nucleus 
as the cell enters mitosis (in our experiments 
this was accomplished through deletion of 
MSN5) is subject to STUbL-mediated 
ubiquitylation (circle labeled Ub) and 
degradation. Other non–STUbL-dependent 
pathways for the regulation of Siz1 activity 
and levels may exist, and the exact structures 
of the Siz1 conjugates are not known.
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with a carboxy-terminal GFP tag in CEN/LEU2 plasmid pAA3 (Sesaki 
and Jensen, 1999; Cook et al., 2009). Nuclear versus cytosolic local-
ization of GFP-tagged constructs was confirmed using 4′,6-diamid-
ino-2-phenylindole. For galactose-inducible expression of Siz1(∆440) 
in yeast, the open reading frame (ORF) was PCR amplified and 
cloned into the pCR8/GW/TOPO entry vector (Life Technologies, 
Grand Island, NY) and then recombined into pAG425GAL-ccdB-
HA/LEU2 (plasmid 14249; Addgene, Cambridge MA), forming Gal-
Siz1∆440-HA/LEU2/2 μ (plasmid BOK795). For in vivo pull-down as-
says a plasmid expressing GST-tagged Slx5 (YSC4515-202484078) 
was purchased from the Thermo Scientific Life Science Research 
Yeast (Thermo Scientific, Pittsburgh PA) GST-tagged ORF Collection 
(formerly Open Biosystems). For two-hybrid constructs, ORFs or 
truncations of the indicated genes were PCR amplified, homolo-
gously recombined into gapped pOAD and pOBD2 vectors, and 
transformed into AH109 (YOK1220) strains as specified (Yeast Re-
source Center, University of Washington, Seattle, WA). Two-hybrid 
interactions were scored on dropout media lacking adenine as spec-
ified in the Clontech Yeast Protocols Handbook (protocol PT3024-1; 
Clontech Laboratories). Chromosomal tagging and gene deletions 
in yeast were carried out by PCR-based homologous recombination 
(Longtine et al., 1998). Strain YOK821 (slx5∆) was used to epitope 
tag SIZ1 with a 13-myc epitope tag. Briefly, primers OOK663 and 
OOK662 were used to amplify the 13xmyc-TADH1-His3MX6 cas-
sette with 40 base pairs of SIZ1 sequence homology from the plas-
mid pFA6a-13myc-His3MX6 (Longtine et al., 1998). PCR amplifica-
tion was carried out using the Phusion High-Fidelity PCR kit (E0553S; 
New England BioLabs, Ipswich, MA) with dimethylsulfoxide and 
high-GC buffer as recommended by the manufacturer. For transfor-
mation, 6.5 μg of purified SIZ1-13myc-His3MX6 PCR product was 
combined with 4 OD units of competent slx5∆ (YOK821) cells, incu-
bated for 30 min at 30°C, heat shocked at 42°C for 30 min, and 
plated on SD –His dropout. Resulting colonies were screened by 
Western blotting using an anti-myc antibody. Subsequently, the 
SIZ1-myc slx5∆ strain (YOK2264) was backcrossed to YOK819 to ob-
tain SIZ1-myc SLX5(WT) progeny (YOK2286). An amplicon of SIZ1-
13myc was also cloned into a Gateway-compatible pRS315 plasmid. 
The msn5-null mutant was constructed by introducing a hygromycin 
deletion cassette with 78–base pair flanking sequence homology to 
msn5 gene upstream and downstream region. The primer pairs for 
amplification of a MSN5-specific hygromycin deletion cassette in 
plasmid pAG32 were OOK763 and OOK764 and for re-PCR were 
OOK767 (MSN5[−78 to −19] and OOK768 (MSN5[+3692–3751]). 
All primer sequences are available upon request.
Recombinant proteins
For the in vitro ubiquitylation and pull-down assays recombinant 
MBP-Slx5, MBP-Slx8, and His6-Ubc4 were prepared as previously 
reported (Xie et al., 2007; Fryrear et al., 2012). Recombinant 
Siz1(∆440) was expressed from plasmid pT-77-SIZ1∆440-His ob-
tained from Addgene (plasmid 16087; Takahashi and Kikuchi, 2005). 
CUP1-driven UbiG76A and mycUbi-G76A plasmids expressing deu-
biquitylation-resistant mutants of ubiquitin were a gift from Tommer 
Ravid (The Hebrew University of Jerusalem).
Pull-down assays, affinity purification, and protein extracts
MBP-Slx5, MBP-Slx8, and T7-Siz1∆440 were overexpressed in 
BL21(DE3) or *R cells by isopropyl-β-d-thiogalactoside induction as 
previously described (Xie et al., 2007). We combined 50 OD units of 
cells overexpressing either MBP-Slx5 or MBP-Slx8 with 50 OD units 
of cells overexpressing T7-Siz1∆440. We also collected 50 OD units 
of cells overexpressing T7-Siz1∆440. Whole-cell protein extracts 
STUbL-dependent manner, and accumulates sumoylated adducts 
of Siz1 when SLX5 is absent (Figure 7C). These sumoylated adducts 
of Siz1 may be retained in nuclei of slx5∆ cells, because we find a 
∼20% reduction of Siz1 localization to the septin ring when cells are 
arrested in nocodazole (C.E., J.W.W., and O.K., unpublished obser-
vations). However, another possibility is that autosumoylation of 
Ubc9, which was recently shown to negatively affect septin sumoyla-
tion (Ho et al., 2011), is increased in slx5∆.
Are there nuclear versus cytosolic STUbL functions? Slx5 is a nu-
clear protein, and there is no evidence that it functionally interacts 
with sumoylated proteins in the cytosol. Only the truncated Slx5 
protein lacking a domain involved in nuclear localization and puta-
tive dimerization, Slx5(1–207), associates with the sumoylated sep-
tin ring in G2/M-arrested cells. Although not physiologically rele-
vant, this helps to delineate a domain involved in nuclear localization 
of Slx5 and shows which SIMs are involved in targeting the Slx5/Slx8 
STUbL. Other cytosolic proteins are known to use a SUMO-binding 
strategy to be recruited to the septin ring in a cell cycle–dependent 
manner (Elmore et al., 2011). Is it possible that the various yeast 
STUbLs are separated into distinct cellular compartments? For ex-
ample, Slx5/Slx8 may function in the nucleus, whereas sumoylated 
proteins in the cytosol are degraded by other STUbLs. Consistent 
with this hypothesis, the STUbL protein Ris1 relocalizes to the cyto-
sol upon replication stress, and other recent work suggests that Ris1 
targets the microtubule-associated protein Pac1 in the cytosol 
(Alonso et al., 2012; Tkach et al., 2012).
In conclusion, we predict that the degradation of Siz1 by Slx5/
Slx8 plays an important physiological role in reducing nuclear SUMO 
E3 ligase activity as the cell enters mitosis. This novel process likely 
works in parallel to the mitotic nuclear export pathway of Siz1 and 
may help to prevent the accumulation of specific nuclear SUMO con-
jugates that interfere with cell cycle progression (see Introduction). 
Considering that Slx5 and Siz1 are evolutionarily conserved proteins, 
we predict that the STUbL-mediated regulation of SUMO-E3 ligases 
extends to RNF4 and PIAS proteins in mammalian cells. Indeed, our 
preliminary analysis indicates that RNF4 can interact with PIAS1 in 
yeast two-hybrid and pull-down assays (Kerscher, Westerbeck, and 
Semmes, unpublished observations). It will be interesting to deter-
mine whether RNF4 affects the turnover of PIAS1 in mammalian 
cells. This would further support the emerging theme of interconnec-
tion and interdependence of SUMO and ubiquitin systems.
MATERIALS AND METHODS
Yeast strains, media, and plasmids
Yeast strains and plasmids used in this study are listed in Table 1. 
Unless otherwise noted, yeast media preparation and manipulation 
of yeast cells were performed as previously reported (Guthrie and 
Fink, 2002). All strains were grown at 30°C unless otherwise noted.
Cell synchronization and drug treatments
Where indicated, yeast cells were synchronized in G2/M phase by 
incubating logarithmically grown cells in 15 μg/ml nocodazole 
(358240500; Acros Organics) for 3 h at 30°C. For cycloheximide 
chase experiments, 25 μg/ml cycloheximide (C7698; Sigma-Aldrich, 
St. Louis, MO) was added to G2/M-arrested cells. We harvested 
2.5 OD units of cells at the indicated time points. Cells were arrested 
in S phase by addition of 0.1 M hydroxyurea (H8627; Sigma-Aldrich) 
and incubation at 30°C for 3 h.
Cloning and epitope tagging of yeast genes
Slx5 and Slx5 domains under control of its endogenous promoter 
were PCR amplified from yeast genomic DNA and placed in-frame 
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Name Pertinent genotype or background Plasmid or construction Reference
MHY500 (YOK819) Mata his3-∆200 leu2-3, 112 ura3-52 lys2-
801trp1-1gal2
Li and Hoch-
strasser (2003)
MHY501 (YOK820) Matα his3-∆200 leu2-3, 112 ura3-52 lys2-
801trp1-1 gal2
BY4741 (YOK1322) MATa leu2∆0 met15∆0 ura3∆0 Brachmann et al. 
(1998) 
JD52 (YOK2062) MATa ura3-52 his3-∆200 leu2-3112 trp1-∆63 
lys2-801
Dohmen et al. 
(1995) 
AH109 (YOK1220) MATa, trp1-901, leu2-3, 112, ura3-52, his3-
200, gal4∆, gal80∆, LYS2::GAL1UAS-GAL-
1TATA-HIS3, GAL2UAS-GAL2TATA-ADE2, 
URA3::MEL1UASMEL1TATA-lacZ, MEL1
Cat. No. 630444; 
Clontech, 
Mountain View, 
CA
YOK1369 BY4741 (YOK1322) SLX5(1-50)-GFP/LEU2 (BOK514) This study
YOK1370 BY4741 (YOK1322) SLX5(1-104)-GFP/LEU2 (BOK515) This study
YOK1372 BY4741 (YOK1322) SLX5(1-310)-GFP/LEU2 (BOK517) This study
YOK1373 BY4741 (YOK1322) SLX5(1-414)-GFP/LEU2 (BOK518) This study
YOK1374 BY4741 (YOK1322) SLX5(1-517)-GFP/LEU2 (BOK519) This study
YOK1375 BY4741 (YOK1322) SLX5(1-207)-GFP/LEU2 (BOK507) This study
YOK1830 MHY500 SLX5(208-310)-GFP/LEU2 (BOK637) This study
YOK1408 AH109 SLX5(1-104)-BD/TRP; SLX5-AD/LEU2 
(BOK289)
This study
YOK1411 AH109 SLX5(1-207)-BD/TRP; SLX5-AD/LEU2 
(BOK289)
This study
YOK1414 AH109 SLX5(1-310)-BD/TRP; SLX5-AD/LEU2 
(BOK289)
This study
YOK1417 AH109 SLX5(1-414)-BD/TRP; SLX5-AD/LEU2 
(BOK289)
This study
YOK1420 AH109 SLX5(1-517)-BD/TRP; SLX5-AD/LEU2 
(BOK289)
This study
YOK1423 AH109 SLX5(51-620)-BD/TRP; SLX5-AD/LEU2 
(BOK289)
This study
YOK1425 AH109 SLX5(105-620)-BD/TRP; SLX5-AD/LEU2 
(BOK289)
This study
YOK1428 AH109 SLX5(208-620)-BD/TRP; SLX5-AD/LEU2 
(BOK289)
This study
YOK1431 AH109 SLX5(311-620)-BD/TRP; SLX5-AD/LEU2 
(BOK289)
This study
YOK1434 AH109 SLX5(415-620)-BD/TRP; SLX5-AD/LEU2 
(BOK289)
This study
YOK1437 AH109 SLX5(1-104)-BD/TRP; SLX8-AD/LEU2 
(BOK311)
This study
YOK1440 AH109 SLX5(1-207)-BD/TRP; SLX8-AD/LEU2 
(BOK311)
This study
YOK1443 AH109 SLX5(1-310)-BD/TRP; SLX8-AD/LEU2 
(BOK311)
This study
YOK1446 AH109 SLX5(1-414)-BD/TRP; SLX8-AD/LEU2 
(BOK311)
This study
YOK1449 AH109 SLX5(1-517)-BD/TRP; SLX8-AD/LEU2 
(BOK311)
This study
TABLE 1: Strains and plasmids used in this study. 
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YOK1452 AH109 SLX5(51-620)-BD/TRP; SLX8-AD/LEU2 
(BOK311)
This study
YOK1455 AH109 SLX5(105-620)-BD/TRP; SLX8-AD/LEU2 
(BOK311)
This study
YOK1458 AH109 SLX5(208-620)-BD/TRP; SLX8-AD/LEU2 
(BOK311)
This study
YOK1461 AH109 SLX5(311-620)-BD/TRP; SLX8-AD/LEU2 
(BOK311)
This study
YOK1464 AH109 SLX5(415-620)-BD/TRP; SLX8-AD/LEU2 
(BOK311)
This study
YOK1467 AH109 SLX5-BD/TRP (BOK440); SlX5-AD/LEU2 
(BOK289)
This study
YOK1470 AH109 SLX5-BD/TRP (BOK440); SLX8-AD/LEU2 
(BOK311)
This study
YOK1518 AH109 SLX5-BD/TRP (BOK440); SMT3-AD/LEU2 
(BOK571)
This study
YOK1547 AH109 SLX5(1-50)-BD/TRP SMT3-AD/LEU2 
(BOK571)
This study
YOK1550 AH109 SLX5(1-104)-BD/TRP; SMT3-AD/LEU2 
(BOK571)
This study
YOK1553 AH109 SLX5(1-207)-BD/TRP; SMT3-AD/LEU2 
(BOK571)
This study
YOK1556 AH109 SLX5(1-310)-BD/TRP; SMT3-AD/LEU2 
(BOK571)
This study
YOK1559 AH109 SLX5(1-414)-BD/TRP; SMT3-AD/LEU2 
(BOK571)
This study
YOK1562 AH109 SLX5(1-517)-BD/TRP; SMT3-AD/LEU2 
(BOK571)
This study
YOK1565 AH109 SLX5(51-620)-BD/TRP; SMT3-AD/LEU2 
(BOK571)
This study
YOK1568 AH109 SLX5(311-620)-BD/TRP; SMT3-AD/LEU2 
(BOK571)
This study
YOK1571 AH109 SLX5(208-620)-BD/TRP; SMT3-AD/LEU2 
(BOK571)
This study
YOK1574 AH109 SLX5(311-620)-BD/TRP; SMT3-AD/LEU2 
(BOK571)
This study
YOK1577 AH109 SLX5(415-620)-BD/TRP; SMT3-AD/LEU2 
(BOK571)
This study
YOK1580 AH109 SLX5(518-620)-BD/TRP; SMT3-AD/LEU2 
(BOK571)
This study
YOK1583 AH109 SLX5(518-620)-BD/TRP; SLX8-AD/LEU2 
(BOK311)
This study
YOK1586 AH109 SLX5(518-620)-BD/TRP; SLX5-AD/LEU2 
(BOK289)
This study
YOK1589 AH109 SLX5(1-50)-BD/TRP SLX8-AD/LEU2 (BOK311) This study
YOK1592 AH109 SLX5(1-50)-BD/TRP SLX5-AD/LEU2 (BOK289) This study
YOK1595 AH109 SLX5-BD/TRP (BOK440); SIZ1-AD/LEU2 
(BOK582)
This study
YOK1621 AH109 SLX5(1-50)-BD/TRP SIZ1-AD/LEU2 (BOK582) This study
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YOK1625 AH109 SLX5(1-104)-BD/TRP; SIZ1-AD/LEU2 
(BOK582)
This study
YOK1627 AH109 SLX5(1-207)-BD/TRP; SIZ1-AD/LEU2 
(BOK582)
This study
YOK1630 AH109 SLX5(1-310)-BD/TRP; SIZ1-AD/LEU2 
(BOK582)
This study
YOK1633 AH109 SLX5(1-414)-BD/TRP; SIZ1-AD/LEU2 
(BOK582)
This study
YOK1636 AH109 SLX5(1-517)-BD/TRP; SIZ1-AD/LEU2 
(BOK582)
This study
YOK1639 AH109 SLX5(51-620)-BD/TRP; SIZ1-AD/LEU2 
(BOK582)
This study
YOK1642 AH109 SLX5(311-620)-BD/TRP; SIZ1-AD/LEU2 
(BOK582)
This study
YOK1645 AH109 SLX5(208-620)-BD/TRP; SIZ1-AD/LEU2 
(BOK582)
This study
YOK1648 AH109 SLX5(311-620)-BD/TRP; SIZ1-AD/LEU2 
(BOK582)
This study
YOK1651 AH109 SLX5(415-620)-BD/TRP; SIZ1-AD/LEU2 
(BOK582)
This study
YOK1654 AH109 SLX5(518-620)-BD/TRP; SIZ1-AD/LEU2 
(BOK582)
This study
YOK1796 AH109 SLX5(SIMAB)-BD/TRP; SLX8-AD/LEU2 
(BOK311)
This study
YOK1797 AH109 SLX5(SIMAB)-BD/TRP; SLX8-AD/LEU2 
(BOK311)
This study
YOK1798 AH109 SLX5(SIMAB)-BD/TRP; SLX8-AD/LEU2 
(BOK311)
This study
YOK1799 AH109 SLX5(SIMAB)-BD/TRP (BOK627); SMT3-AD/
LEU2 (BOK571)
This study
YOK1800 AH109 SLX5(SIMAB)-BD/TRP(BOK627); SMT3-AD/
LEU2 (BOK571)
This study
YOK1801 AH109 SLX5(SIMAB)-BD/TRP(BOK627); SMT3-AD/
LEU2 (BOK571)
This study
YOK2396 slx5::KanMX4 SIZ1-13xmyc/HIS5 in JD52 YOK 2373 transformed with SIZ1-13xmyc/
HIS5
This study
YOK2397 SIZ1-13xmyc/HIS5 in JD52 YOK 2062 transformed with SIZ1-13xmyc/
HIS5
This study
YOK2514 msn5::HYG SIZ1-13xmyc/HIS5 in JD52 YOK 2397 transformed with msn5::HYG This study
YOK2513 msn5::HYG, slx5::KanMX4 SIZ1-13xmyc/HIS5 YOK 2396 transformed with msn5::HYG This study
YOK3712 
(MHY821)
slx5::KANMX4 Xie et al. (2007)
YOK2264 slx5∆ SIZ1-13xmyc/HIS5 MHY821 transformed with SIZ1-13xmyc/HIS5 This study
YOK2286 SIZ1-13xmyc/HIS5 MHY501 transformed with SIZ1-13xmyc/HIS5 This study
YOK2373 slx5::KANMX4 in JD52 YOK2062 with integrated slx5::KANMX4 
cassette
This study
YOK2505 msn5::HYG in JD52 YOK2062 with integrated msn5::HYG 
cassette
This study
YOK2681 slx5::KANMX4 msn5::HYG in JD52 YOK2062 with integrated slx5::KANMX4 and 
msn5::HYG cassettes
This study
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YOK2738 SIZ1-GFP/HIS5 in JD52 YOK 2062 transformed with SIZ1-GFP/HIS5 This study
YOK2751 slx5::KANMX4 SIZ1-GFP/HIS5 in JD52 YOK 2373 transformed with SIZ1-GFP/HIS5 This study
YOK2624 msn5::HYG SIZ1-GFP/HIS5 in JD52 YOK2505 transformed with SIZ1-GFP/HIS5 This study
YOK2735 slx5::KANMX4 msn5::HYG SIZ1-GFP/HIS5 in 
JD52
YOK2681 transformed with SIZ1-GFP/HIS5 This study
YOK2757 slx5::KANMX4 in JD52 YOK2373 transformed with SIZ1-13xmyc/
LEU2 on pRS315 (BOK982)
This study
YOK2759 msn5::HYG in JD52 YOK2505 transformed with SIZ1-13xmyc/
LEU2 on pRS315 (BOK982)
This study
YOK2761 slx5::KanMX4 msn5::HYG in JD52 YOK2681 transformed with SIZ1-13xmyc/
LEU2 on pRS315 (BOK982)
This study
YOK2501 MHY3765: MATalpha ura3-52, lys2-801, 
trp1-∆63, his3-∆200, leu2-∆1, ubc4::HIS3, 
ubc6::TRP1, alpha2::KanMX
Xie et al. (2010)
YOK2507 YOK2501 + pGAL1/10-GST-Slx5 BOK629 (GAL1/10-GST-Slx5) (Open Biosys-
tems Yeast GST Collection) transformed into 
YOK2501
This study
YOK2508 YOK2501 + pGAL1-ccdB-Siz1∆440-HA BOK795 transformed into 2501 This study
YOK2509 YOK250 + pGAL1/10-GST-Slx5; pGAL1-ccdB-
Siz1∆440-HA
BOK629 and BOK795 transformed into 
YOK2501
This study
YOK2379 pYES2.1-GAL- Siz1∆440-V5/His6-TOPO; 
CUP1-UbiG76A-myc in JD52
BOK794 and BOK309 transformed into 
YOK2062
YOK2381 slx5::KAN YOK2373 + pYES2.1-GAL- 
Siz1∆440-V5/His6-TOPO; CUP1-UbiG76A-
myc
BOK794 and BOK309 transformed into 
YOK2373
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for 15 min at 4°C. We added 100 μl of clarified lysate (correspond-
ing to 20 OD units) to 100 μl of immobilized glutathione agarose 
(15160; Thermo Scientific) that had been equilibrated with HNT buf-
fer and increased the final volume to 1 ml with HNT buffer plus 25 
mM NEM, 1 mM sodium orthovanadate, and 1× protease inhibitor 
cocktail (1860932; Thermo Scientific). Extracts were rotated top 
over bottom with the glutathione agarose for 2.5 h at 4°C. Agarose 
beads were then washed five times with HNT buffer. We saved 100 
μl of the flowthrough and precipitated proteins by addition of 1 ml 
of 20% trichloroacetic acid (TCA). Glutathione agarose–bound pro-
teins were eluted by top-over-bottom rotation with 100 μl of elution 
buffer (50 mM HEPES at pH 7.3, 200 mM NaCl, 10 mM reduced 
glutathione [120000010; Acros Organics]) for 5 min. Three elutions 
were performed and pooled before analysis of proteins by SDS–
PAGE and Western blotting. The Ubi(G76A) construct was induced as 
previously reported (Ravid and Hochstrasser, 2007), and extracts 
were prepared as listed except that 20 μM MG132 was added to the 
cultures and anti–V5-agarose was used for immunoprecipitations 
(A7345; Sigma-Aldrich).
Preparation of whole-cell yeast extracts, gel electrophoresis, 
and Western blotting
Whole-cell yeast extracts were prepared by TCA glass bead lysis. 
Whole-cell protein extracts corresponding to ∼0.2 OD unit were sep-
arated on a precast NuPAGE Novex 4–12% Bis-Tris gels (NP0321; Life 
Technologies) or home-made 8% Tris-glycine gels. After separation, 
proteins were transferred to polyvinylidene difluoride membrane 
(IPVH00010; Millipore, Billerica, MA) for 25 min at 19 V. Blots were 
were then isolated and passed over a column containing amylose 
resin (E8021L; New England BioLabs). Proteins bound to the amy-
lose resin were eluted with 1× LDS Sample Buffer (NP0007; Life Tech-
nologies) and analyzed by Western blotting as described later. To 
determine whether Slx5 and Siz1 interacted in vivo, GAL1/10-GST-
Slx5 (BOK 629, Open Biosystems Yeast GST Collection YSC4515-
202484078), pAG425-GAL1-ccdB-Siz1(∆440)-HA (BOK795), or both 
GST-Slx5 and Siz1(∆440)-HA were transformed into ubc4∆ ubc6∆ 
cells (YOK2501, Xie et al., 2010) to form YOK2507, YOK2508, and 
YOK2509, respectively. Copurification experiments were done as 
described in Szymanski and Kerscher (2013). Transformants were 
grown in 33 ml of the appropriate selective media containing 2% 
sucrose until mid–log phase (OD600 = 0.8–1.0). At this point, 17 ml 
of 3× yeast extract peptone (YEP) with 6% galactose was added to 
each culture, for a final concentration of 1× YEP and 2% galactose in 
a final volume of 50 ml. Cells were allowed to grow for another 6 h 
before harvesting. We washed 200 OD units worth of yeast cells 
with 1× ice-cold phosphate-buffered saline plus 1× protease inhibi-
tor cocktail (1860932; Thermo Scientific), snap froze them in liquid 
nitrogen, and stored them at −80°C until further use. To extract pro-
teins, frozen cell pellets were lysed in 500 μl of HNT buffer (50 mM 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES] at pH 
7.3, 200 mM NaCl, 1% Triton X-100) containing 25 mM N-ethylma-
leimide (NEM), 1 mM sodium orthovanadate, and 1× protease in-
hibitor cocktail (G6521; Promega, Madison, WI), and 200 μl of acid-
washed beads (425–600 μm; Sigma-Aldrich) were placed in an Omni 
Bead Ruptor 24 (six 20-s pulses with 1 min on slushy ice between 
each pulse). The lysate was clarified by centrifugation at 15,000 rpm 
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blocked in TBS (150 mM NaCl, 50 mM Tris-HCl at pH 7.4) contain-
ing 4% milk for 1 h and then incubated in 4% milk containing 
primary antibody overnight, followed by incubation with secondary 
antibodies for 1–3 h at ambient temperature. After antibody incu-
bations, blots were extensively washed in TBS plus 0.1% Tween 20 
(TBST). Anti-GST antibody (1:5000 dilution, ab6613; Abcam), anti-
hemagglutinin (HA) antibody (1:10,000, ab9110; Abcam), anti-T7 
(1:10,000 dilution, 69522-3; Novagen [EMD Millipore], Billerica, 
MA), anti-myc (1:5000, MMS-150R; Covance, Princeton, NJ), anti-
Pgk (1:10,000, A6457; Life Technologies), anti-GST (1:5000, ab6613, 
Abcam), anti-FLAG (1:10,000, F3165; Sigma-Aldrich), anti-mouse 
horseradish peroxidase (HRP; 1:15,000, ab9740; Abcam), and anti-
rabbit HRP (1:20,000, ab6721; Abcam). Proteins were visualized on 
film using enhanced chemiluminescence substrate (Immobilon 
Western ECL substrate WBKL S0 100; Millipore).
In vitro ubiquitylation reactions
Sizing and quantitation of enzymes and substrates used in our in 
vitro ubiquitylation assays were performed with a Protein 230 kit on 
the Agilent 2100 Bioanalyzer according to the manufacturer’s 
instructions. The 10× ubiquitylation buffer, E1 enzyme (Uba1), 
ATP, and 20× ubiquitin were provided in a commercial ubiquityla-
tion kit (Enzo). Ubiquitylation buffer, inorganic pyrophosphatase 
(IPP; 100 U/ml), dithiothreitol (DTT; 50 μM), E1 (Uba1), E2 (Ubc4), 
and E3 enzyme (Slx5-Slx8) were combined with purified substrate 
protein (T7-Siz1∆440) and ubiquitin as previously reported (Xie 
et al., 2007). Reactions totaled 27 μl and were incubated in a 30°C 
heat block for 3 h. Molar ratios of components in the STUbL ubiq-
uitylation reactions were as follows (μM): E1(Uba1), 0.1; E2(Ubc4), 
0.4; E3 (Slx5/Slx8), 0.12 each; and substrate (Siz1∆440), 0.03. Reac-
tions were stopped by adding an equal volume of SUTEB sample 
buffer (0.01% bromophenol blue, 10 mM EDTA, 1% SDS, 50 mM 
Tris at pH 6.8, 8 M urea) containing DTT (5 μl of 1 M DTT/1 ml 
SUTEB sample buffer). Protein products were boiled in a 65°C heat 
block for 10 min, frozen in liquid nitrogen, stored at −80°C, and 
analyzed by Western blot as described.
Fluorescence microscopy
Images of live cells were collected using a Zeiss Axioskop fitted with 
a Retiga SRV camera (Q-imaging), i-Vision software (BioVision Tech-
nologies), and a Uniblitz shutter assembly (Rochester, NY). Pertinent 
filter sets for the applications include CZ909 (GFP), XF114-2 (CFP), 
and XF104-2 (YFP; Chroma Technology Group, Bellows Falls, VT). 
Where applicable, images were normalized using i-Vision software 
and pseudocolored and adjusted using Photoshop software (Adobe 
Systems, San Jose, CA).
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